📋 Tender Overview
Contract awarded for Pharmaceutical products - medicines included in various national programs { "detected_language": "romanian", "translated_text": "lot-0001, title: atezolizumab/conc.pt sol.perf.1200mg/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 1,050,861.60 lei, for which 0.9999% gp - 10,508.00 lei will be requested. lot-0002, title: bleomycin sulfate/pul.pt.sol.inj./perf.15000ui/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 10,883.40 lei, for which (0.9923%) gp - 108.00 lei will be requested. lot-0004, title: carfilzomib/pulb.pt.sol.perf. 60mg/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 980,771.00 lei, for which (0.9999%) gp - 9,807.00 lei will be requested. lot-0005, title: cetuximab/sol.perf.100mg/20ml/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 553,263.48 lei, for which (0.9999%) gp - 5,532.00 lei will be requested. lot-0006, title: doxorubicin 50mg/sol.inj. (2mg/ml-25ml)/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 15,744.00 lei, for which (0.9972%) gp - 157.00 lei will be requested. lot-0007, title: gemcitabine 2g/conc.pt.sol.perf.2g/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 21,108.00 lei, for which (0.9996%) gp - 211.00 lei will be requested. lot-0008, title: panitumumab 100mg/conc.pt.sol.perf.100mg/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 167,443.20 lei, for which (0.9997%) gp - 1,674.00 lei will be requested. lot-0009, title: panitumumab 400mg/conc.pt.sol.perf.400mg/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 598,972.32 lei, for which (0.9999%) gp - 5,989.00 lei will be requested. lot-0010, title: pemetrexed/pulb.pt.conc.pt.sol.perf. 500mg /fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 129,035.52 lei, for which (0.9997%) gp - 1,290.00 lei will be requested. lot-0011, title: ramucirumab/conc.pt sol.perf. 100mg (ct.x2fl)/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 82,724.16 lei, for which (0.9997%) gp - 827.00 lei will be requested. lot-0012, title: trastuzumab emtasine 100mg/pulb.pt.con.pt.sol.perf. 100mg/5ml/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 303,744.00 lei, for which (0.9999%) gp - 3,037.00 lei will be requested. lot-0013, title: obinutuzumab 1g/ conc.pt sol.perf. 1000mg/40ml/fl, description: the estimated minimum and maximum quantities are according to annex 1 quantities-values in the specifications. in accordance with the provisions of the specifications, the value of the highest cs will be 383,555.88 lei, for which (0.9999%) gp - 3,835.00 lei will be requested. lot-0014, title: polatuzumab vedotin 30mg/pulb.pt.conc.pt.sol.perf 30mg/fl, description: estimated value excluding vat: 506880.00 ron.Pharmaceutical products - medicines included in various national programs